By Thermo Fisher Scientific, Inc.

closed 6/6/2019 via PR Newswire

Thermo Fisher Scientific, Inc., acquired HighChem, Ltd.

synopsis: Thermo Fisher Scientific, the world leader in serving science, announced that it has completed the acquisition of HighChem, Ltd., a leading developer of mass spectrometry software based in Bratislava, Slovakia. HighChem software solutions are used to analyze complex data and identify small molecules in pharmaceutical and metabolomics laboratories.
buyer: Thermo Fisher Scientific, Inc. (TMO:$24,630.00)
Thermo Fisher Scientific Inc. is the world leader in serving science, helping their customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. "
target: HighChem, Ltd.
HighChem, Ltd. is a leading developer of mass spectrometry software based in Bratislava, Slovakia. HighChem software solutions are used to analyze complex data and identify small molecules in pharmaceutical and metabolomics laboratories.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/6/2017 via BusinessWire

Thermo Fisher Scientific, Inc., acquired Core Informatics LLC

synopsis: Thermo Fisher Scientific Inc. announced that it has acquired Core Informatics, which provides a cloud-based platform supporting scientific data management. Core’s offerings will enhance Thermo Fisher’s existing informatics solutions and complement its cloud platform, which supports the company’s genetic analysis, qPCR and proteomics systems.
buyer: Thermo Fisher Scientific, Inc. (TMO:$24,630.00)
Thermo Fisher Scientific Inc. offers an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. They help customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. "
target: Core Informatics LLC
Core Informatics partners with customers in biopharma, genomics, and other industries to deliver lab informatics solutions to derive more value and insight from scientific data. Core Informatics provides the scalable Platform for Science that enables customers to build workflows for specific needs.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/6/2019 via PR Newswire

Thermo Fisher Scientific, Inc., acquired HighChem, Ltd.

synopsis: Thermo Fisher Scientific, the world leader in serving science, announced that it has completed the acquisition of HighChem, Ltd., a leading developer of mass spectrometry software based in Bratislava, Slovakia. HighChem software solutions are used to analyze complex data and identify small molecules in pharmaceutical and metabolomics laboratories.
buyer: Thermo Fisher Scientific, Inc. (TMO:$24,630.00)
Thermo Fisher Scientific Inc. is the world leader in serving science, helping their customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. "
target: HighChem, Ltd.
HighChem, Ltd. is a leading developer of mass spectrometry software based in Bratislava, Slovakia. HighChem software solutions are used to analyze complex data and identify small molecules in pharmaceutical and metabolomics laboratories.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/7/2019 via Company Press Release

MilliporeSigma, acquired BSSN Software GmbH

synopsis: MilliporeSigma has acquired BSSN Software, a Germany-based laboratory informatics company that makes data more readily accessible for ease of integration, collaboration, analysis, and long-term archiving. BSSN Software is known for developing and marketing data management and integration software that unifies data from instruments and data systems.
buyer parent: Merck KGaA
buyer: MilliporeSigma
MilliporeSigma, a division of Merck KGaA, offers a broad spectrum of proven tools and technologies, together with performance solutions innovations, dedicated to helping customers succeed in the research, development, and production of biotechnology and pharmaceutical drug therapies. "
target: BSSN Software GmbH
Germany-based BSSN Software is a fast-growing laboratory informatics company. BSSN Software facilitates the standardization and interoperability in the laboratory by assisting end-users and instrument vendors in adopting standards to make valuable scientific data more accessible and usable.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/9/2017 via Company Press Release

Qiagen N.V., acquired OmicSoft Corporation

synopsis: QIAGEN N.V. announced the acquisition of OmicSoft Corporation, providing access to OmicSoft’s powerful multi-omics data management infrastructure solution as well as expertly curated ‘omics’ data sets that complement QIAGEN’s bioinformatics portfolio that are relied upon by customers worldwide to gain valuable insights into complex biological data.
buyer: Qiagen N.V. (QGEN:$1,269.61)
QIAGEN N.V., a Netherlands holding company, is the leading global provider of Sample & Assay Technologies, used to transform biological materials into valuable molecular information. Qiagen has four customer classes: Molecular Diagnostics, Applied Testing, Pharma, & Academia. "
target: OmicSoft Corporation
OmicSoft is recognized for its suite of cutting-edge software solutions that enable scientists and researchers to efficiently analyze and visualize their own data sets and compare them to massive volumes of publicly available ‘omics’ data sets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/2/2020 via BusinessWire

Wiley, purchased Informatics products from Bio-Rad Laboratories

synopsis: John Wiley and Sons Inc., a global leader in research and education, announced the acquisition of Bio-Rad Laboratories, Inc.’s Informatics products including the company’s spectroscopy software and spectral databases.
buyer: Wiley (NYSE:JW.A:$1,848.05)
Wiley drives the world forward with research and education. Through publishing, platforms and services, they help students, researchers, universities, and corporations to achieve their goals in an ever-changing world. "
seller: Bio-Rad Laboratories (BIO:$2,311.66)
The acquisition includes the Informatics Spectroscopy Software and Spectral Databases from Bio-Rad Laboratories, a manufacturer of products for the life science research and clinical diagnostics markets. The company was founded in 1952 in Berkeley, California
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/2/2015 via PR Newswire

Tute Genomics, acquired Knome, Inc.

synopsis: Tute Genomics, the leader in clinical sequencing infomatics, announced its acquisition of key assets of Knome, a renowned human-genome interpretation company whose systems and services helped spearhead several of the greatest commericial advancements in modern human genetics.
buyer: Tute Genomics
Tute Genomics provides a cloud-based genome informatics solution to help diagnostic labs and health systems process next-generation sequencing data in a secure fashion. Tute is powering the world's genomic knowledge through enterprise informatics, genome interpretation, and clinical insights. "
target: Knome, Inc.
Knome, Inc. is a leading provider of human genome interpretation systems and services. Knome provides tools and solutions that help researchers, drug developers, and clinicians determine the genetic basis of human disease and drug response.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/5/2019 via PR Newswire

Beckman Coulter, Inc, acquired Cytobank

synopsis: Beckman Coulter, a company that is advancing healthcare to enhance the diagnostic laboratory’s role in improving healthcare outcomes, announced its acquisition of Cytobank, a cloud-based analysis platform utilizing machine learning algorithms for collaborative biomedical research.
buyer parent: Danaher Corporation
buyer: Beckman Coulter, Inc (BEC:$0.00)
Beckman Coulter is committed to advancing healthcare by applying science, technology and the creativity of their teams to enhance the diagnostic laboratory’s role in improving healthcare outcomes. Their diagnostic systems are used in complex biomedical testing and are found around the globe. "
target: Cytobank
Cytobank Inc. is a cloud-based analysis platform utilizing machine learning algorithms for collaborative biomedical research. Pharmaceutical, biotechnology, and academic researchers around the world use their SaaS solution to develop deep understandings of complex biology at the single cell level.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/10/2016 via PR Newswire

Sunquest Information Systems, acquired UNIConnect LC

synopsis: Provider of diagnostics informatics solutions to more than 1,700 laboratories, Sunquest Information Systems, Inc. announced the acquisition of the Salt Lake City-based software firm UNIConnect® L.C. UNIConnect specializes in software for molecular laboratories and augments Sunquest's molecular diagnostics solution.
buyer parent: Roper Technologies, Inc.
buyer: Sunquest Information Systems
Sunquest Information Systems Inc. provides diagnostics informatics solutions to more than 1,700 laboratories. Since 1979, Sunquest has helped laboratories and healthcare organizations across the world optimize financial results, enhance efficiency and improve the quality of patient care. "
target: UNIConnect LC
Based in Salt Lake City, UT, UNIConnect® L.C. has created a Laboratory Information Management System (LIMS) platform that marries breakthrough software technology with unparalleled customization and configuration control to advance the "omic" sciences and precision medicine.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/1/2015 via BusinessWire

Ambry Genetics, acquired Progeny Software Inc.

synopsis: Ambry Genetics announced the acquisition of Progeny Software, LLC. This acquisition marries the premier clinical genetics laboratory with the gold standard pedigree software company, effectively redefining Ambry as a complete genetics services company on the forefront of personalized medicine.
buyer: Ambry Genetics
Ambry leads in clinical genetic diagnostics and genetics software solutions, combining both to offer the most comprehensive testing menu in the industry. Ambry has established a reputation for sharing data while safeguarding patient privacy and unparalleled service. "
target: Progeny Software Inc.
Progeny has increasingly enhanced the technology required to manage all types of genetic data. Whether it be related to pedigrees, providing genotype management and analysis, or providing a full LIMS system, Progeny is committed to bring solutions to the table for the customers they serve.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/10/2018 via BusinessWire

Zymergen, acquired Radiant Genomics

synopsis: Zymergen, a molecular technology company, announced the acquisition of Radiant Genomics, a leader in functional metagenomics research. Radiant Genomics has developed a robust industrial platform for natural product and gene discovery that allows scientists to rapidly identify, produce, and test products encoded in the genomes of organisms.
buyer: Zymergen
Zymergen is a molecular technology company ushering in a new age of manufacturing and industrial innovation. Leveraging the power of machine learning, automation, and bioengineering, they discover new molecular products that touch every industry. "
target: Radiant Genomics
Radiant Genomics is a leader in functional metagenomics research. Radiant Genomics has developed a robust industrial platform for natural product and gene discovery that allows scientists to rapidly identify, produce, and test products encoded in the genomes of millions of organisms.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/7/2016 via PR Newswire

Elsevier B.V., acquired Hivebench

synopsis: Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced the acquisition of Hivebench, the flagship product of researcher application developer Shazino, based in Lyon, France. Hivebench is a digital laboratory notebook that helps researchers.
buyer parent: RELX Group plc
buyer: Elsevier B.V.
Elsevier is a provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. "
target parent: Shazino
target: Hivebench
Hivebench is a digital laboratory notebook that helps researchers prepare, conduct and analyze experiments, methods, and protocols in one place, saving them valuable time.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/16/2018 via PR Newswire

Sophia Genetics, acquired Interactive Biosoftware

synopsis: SOPHiA GENETICS, global leader in Data-Driven Medicine, announced that it has completed the acquisition of French-based tech company Interactive Biosoftware (IBS), the creators of Alamut®, the most used decision support software for clinical genomic data interpretation. Alamut® is currently deployed in over 450 hospitals.
buyer: Sophia Genetics
Based in Switzerland, SOPHiA GENETICS is a health tech company which has developed SOPHiA AI, the most advanced technology for clinical genomics, helping healthcare professionals better diagnose and treat patients. "
target: Interactive Biosoftware
Interactive Biosoftware was founded in Rouen, France, by a group of medical and computer scientists focusing on practical software applications for health care and life sciences, particularly in the field of genomics.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/14/2018 via BusinessWire

Illumina, Inc., acquired Edico Genome Inc.

synopsis: Illumina, Inc.  announced that it acquired Edico Genome, the leading provider of data analysis acceleration solutions for next-generation sequencing. Edico Genome’s DRAGEN Bio-IT Platform uses field programmable gate array technology in conjunction with proprietary software algorithms to reduce both data footprint and time to results.
buyer: Illumina, Inc. (ILMN:$3,556.00)
Illumina is improving human health by unlocking the power of the genome. Their focus on innovation has established them as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. "
target: Edico Genome Inc.
Based in San Diego and founded in 2013, Edico Genome Inc. develops cutting edge solutions that power the genomic revolution. Their vision is to revolutionize genome sequencing analysis by providing unprecedented speed, scale and accuracy.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/23/2017 via BusinessWire

Omicia, acquired Spiral Genetics

synopsis: Omicia, Inc., a leading provider of clinical genomic data analysis and reporting software, announced that it has acquired Seattle-based Spiral Genetics. Spiral’s advanced tools add multiple variant detection capabilities for next generation sequencing (NGS) to Omicia’s industry-leading software platform.
buyer: Omicia
Clinicians and scientists utilize Omicia’s tools to quickly process and analyze genomic data and ultimately improve patient outcomes. Headquartered in Oakland, California, Omicia was founded by renowned scientists and industry veterans who are pioneers in bioinformatics, genomics and diagnostics. "
target: Spiral Genetics
Headquartered in Seattle, WA, Spiral Genetics is a bioinformatics company that develops high performance software for analyzing next-generation sequencing data. They specialize in large-scale DNA data analysis for medical, pharmaceutical and agricultural research.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/12/2016 via BusinessWire

PierianDx, acquired Tute Genomics

synopsis: PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, announced the acquisition of Tute Genomics, a genomics software company based in Provo, UT. The acquisition furthers PierianDx’s goal to be the most comprehensive, integrated platform to enable personalized medicine for clinical labs.
buyer: PierianDx
Founded in 2011, PierianDx is the leading provider of genomic software. They enable health systems, academic medical centers and commercial labs to deliver patient-specific diagnosis and treatments based on an individual’s DNA. "
target: Tute Genomics
Tute Genomics provides a cloud-based genome informatics solution to help diagnostic labs and health systems process next-generation sequencing data in a secure fashion. Tute is powering the world's genomic knowledge through enterprise informatics, genome interpretation, and clinical insights.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/25/2016 via Company Press Release

Vela Diagnostics Pte. Ltd., purchased Data Interpretation Division from Lifecode, Inc.

synopsis: Vela Diagnostics announced that it has acquired the data interpretation division of Lifecode Inc., a Foster City, California-based cancer molecular company. The data interpretation products and services from Lifecode will be connected to Vela Diagnostics’ Next-Generation Sequencing Sentosa® SQ Reporter Software.
buyer: Vela Diagnostics Pte. Ltd.
Vela Diagnostics is a worldwide supplier of integrated life sciences and diagnostic solutions that help provide customers with valuable molecular information. It delivers innovative technology and products* that address many of the clinical, technical and economic issues facing laboratories. "
seller: Lifecode, Inc.
Lifecode Inc’s data interpretation service provides access to Lifecode’s data integration framework, interpretation and report generation pipelines. Lifecode is a specialized CLIA certified clinical laboratory focused on the genetic basis of human disease.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 5/4/2015 via BusinessWire

Agilent Technologies Inc., will acquire Cartagenia

synopsis: Agilent Technologies Inc. will acquire Cartagenia, a leading provider of software and services for clinical genetics and molecular pathology labs. Cartagenia provides software solutions for variant assessment and reporting of clinical genomics data from next-generation sequencing and microarrays.
buyer: Agilent Technologies Inc. (A:$4,720.00)
Agilent Technologies Inc. is a global leader in life sciences, diagnostics and applied chemical markets. Agilent works with customers in more than 100 countries, providing instruments, software, services and consumables for the entire laboratory workflow. "
target: Cartagenia
Cartagenia helps labs to confidently interpret, report and share genomic variants. Reduce turnaround time, build informed variant assessment pipelines, generate clinical grade lab reports, and manage increasing volumes of data. Bring together CNVs and molecular variation. Use clinical phenotypes.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/18/2020 via BusinessWire

Illumina, Inc., acquired BlueBee

synopsis: Illumina, Inc. is acquiring BlueBee, a cloud-based software company that provides genomics analysis solutions for research and clinical customers. BlueBee has developed a regulatory compliant, secure cloud platform that simplifies access to data and tools, enabling users to easily extract insights from genomic data.
buyer: Illumina, Inc. (ILMN:$3,556.00)
Illumina, Inc. is a biotechnology company. They provide sequencing and array-based solutions for genetic analysis. Their studies help accelerate the studies of personalized medicine and their products are used for applications in life sciences and other emerging health segments. "
target: BlueBee
BlueBee is a cloud-based software company that provides genomics analysis solutions for research and clinical customers. BlueBee has developed a regulatory compliant, secure cloud platform that simplifies access to data and tools, enabling users to easily extract insights from genomic data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/11/2020 via PR Newswire

InVitae, acquired Diploid

synopsis: Invitae Corporation, a leading medical genetics company, has acquired Diploid, a privately held Belgian company that developed Moon, artificial intelligence (A.I.) software capable of diagnosing genetic disorders in minutes based on next-generation sequencing data and patient information.
buyer: InVitae (NVTA:$216.82)
Invitae Corporation is a leading medical genetics company that brings comprehensive genetic information into mainstream medicine to improve healthcare. Invitae's goal is to aggregate the world's genetic tests into a single service with higher quality, faster turnaround time, and lower prices. "
target: Diploid
Belgium-based Diploid provides clinical labs, hospitals, and nation-wide sequencing programs with the tools to diagnose every rare disease patient. Its Moon platform uses AI software capable of diagnosing genetic disorders in minutes based on next-generation sequencing data and patient information.
price ($mm)
$95
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/30/2015 via PR Newswire

Human Longevity, Inc., acquired Cypher Genomics

synopsis: Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced that the company has acquired Cypher Genomics, Inc., a leading genome informatics company offering highly accurate, rapid and robust human genomic interpretation software solutions.
buyer: Human Longevity, Inc.
Human Longevity, Inc. (HLI) is the genomics-based, technology-driven company creating the world's largest database of whole genome, phenotype and clinical data. HLI is developing and applying large scale computing and learning to make novel discoveries to revolutionize the practice of medicine. "
target: Cypher Genomics
Cypher Genomics is a leading genome informatics company offering a highly accurate, rapid and robust interpretation software solution for users of human genome sequencing.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/6/2010 via Market Wire

CompareNetworks, Inc., purchased Two Titles from International Scientific Communications, Inc.

synopsis: CompareNetworks, Inc., a leading provider of online b-to-b marketplaces for the scientific and healthcare industries, acquired the titles of American Laboratory and American Biotechnology Laboratory from International Scientific Communications (ISC), Shelton, CT.
buyer parent: Alta Communications
buyer: CompareNetworks, Inc.
CompareNetworks operates targeted, online, b-to-b marketplaces for professionals worldwide. CompareNetworks integrates online marketplaces, email newsletters, video, whitepapers and editorial content to bring buyers and sellers together. "
seller: International Scientific Communications, Inc.
International Scientific Communications, Inc. publishes journals, editorial tabloids, and technical articles on analytical chemistry and life sciences for the chemists and life scientists. Its publications provide news and information in the biotechnology, drug discovery, and many others.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/6/2019 via PR Newswire

Thermo Fisher Scientific, Inc., acquired HighChem, Ltd.

synopsis: Thermo Fisher Scientific, the world leader in serving science, announced that it has completed the acquisition of HighChem, Ltd., a leading developer of mass spectrometry software based in Bratislava, Slovakia. HighChem software solutions are used to analyze complex data and identify small molecules in pharmaceutical and metabolomics laboratories.
buyer: Thermo Fisher Scientific, Inc. (TMO:$24,630.00)
Thermo Fisher Scientific Inc. is the world leader in serving science, helping their customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. "
target: HighChem, Ltd.
HighChem, Ltd. is a leading developer of mass spectrometry software based in Bratislava, Slovakia. HighChem software solutions are used to analyze complex data and identify small molecules in pharmaceutical and metabolomics laboratories.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/7/2019 via Company Press Release

MilliporeSigma, acquired BSSN Software GmbH

synopsis: MilliporeSigma has acquired BSSN Software, a Germany-based laboratory informatics company that makes data more readily accessible for ease of integration, collaboration, analysis, and long-term archiving. BSSN Software is known for developing and marketing data management and integration software that unifies data from instruments and data systems.
buyer parent: Merck KGaA
buyer: MilliporeSigma
MilliporeSigma, a division of Merck KGaA, offers a broad spectrum of proven tools and technologies, together with performance solutions innovations, dedicated to helping customers succeed in the research, development, and production of biotechnology and pharmaceutical drug therapies. "
target: BSSN Software GmbH
Germany-based BSSN Software is a fast-growing laboratory informatics company. BSSN Software facilitates the standardization and interoperability in the laboratory by assisting end-users and instrument vendors in adopting standards to make valuable scientific data more accessible and usable.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/9/2017 via Company Press Release

Qiagen N.V., acquired OmicSoft Corporation

synopsis: QIAGEN N.V. announced the acquisition of OmicSoft Corporation, providing access to OmicSoft’s powerful multi-omics data management infrastructure solution as well as expertly curated ‘omics’ data sets that complement QIAGEN’s bioinformatics portfolio that are relied upon by customers worldwide to gain valuable insights into complex biological data.
buyer: Qiagen N.V. (QGEN:$1,269.61)
QIAGEN N.V., a Netherlands holding company, is the leading global provider of Sample & Assay Technologies, used to transform biological materials into valuable molecular information. Qiagen has four customer classes: Molecular Diagnostics, Applied Testing, Pharma, & Academia. "
target: OmicSoft Corporation
OmicSoft is recognized for its suite of cutting-edge software solutions that enable scientists and researchers to efficiently analyze and visualize their own data sets and compare them to massive volumes of publicly available ‘omics’ data sets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/2/2020 via BusinessWire

Wiley, purchased Informatics products from Bio-Rad Laboratories

synopsis: John Wiley and Sons Inc., a global leader in research and education, announced the acquisition of Bio-Rad Laboratories, Inc.’s Informatics products including the company’s spectroscopy software and spectral databases.
buyer: Wiley (NYSE:JW.A:$1,848.05)
Wiley drives the world forward with research and education. Through publishing, platforms and services, they help students, researchers, universities, and corporations to achieve their goals in an ever-changing world. "
seller: Bio-Rad Laboratories (BIO:$2,311.66)
The acquisition includes the Informatics Spectroscopy Software and Spectral Databases from Bio-Rad Laboratories, a manufacturer of products for the life science research and clinical diagnostics markets. The company was founded in 1952 in Berkeley, California
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/2/2015 via PR Newswire

Tute Genomics, acquired Knome, Inc.

synopsis: Tute Genomics, the leader in clinical sequencing infomatics, announced its acquisition of key assets of Knome, a renowned human-genome interpretation company whose systems and services helped spearhead several of the greatest commericial advancements in modern human genetics.
buyer: Tute Genomics
Tute Genomics provides a cloud-based genome informatics solution to help diagnostic labs and health systems process next-generation sequencing data in a secure fashion. Tute is powering the world's genomic knowledge through enterprise informatics, genome interpretation, and clinical insights. "
target: Knome, Inc.
Knome, Inc. is a leading provider of human genome interpretation systems and services. Knome provides tools and solutions that help researchers, drug developers, and clinicians determine the genetic basis of human disease and drug response.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/5/2019 via PR Newswire

Beckman Coulter, Inc, acquired Cytobank

synopsis: Beckman Coulter, a company that is advancing healthcare to enhance the diagnostic laboratory’s role in improving healthcare outcomes, announced its acquisition of Cytobank, a cloud-based analysis platform utilizing machine learning algorithms for collaborative biomedical research.
buyer parent: Danaher Corporation
buyer: Beckman Coulter, Inc (BEC:$0.00)
Beckman Coulter is committed to advancing healthcare by applying science, technology and the creativity of their teams to enhance the diagnostic laboratory’s role in improving healthcare outcomes. Their diagnostic systems are used in complex biomedical testing and are found around the globe. "
target: Cytobank
Cytobank Inc. is a cloud-based analysis platform utilizing machine learning algorithms for collaborative biomedical research. Pharmaceutical, biotechnology, and academic researchers around the world use their SaaS solution to develop deep understandings of complex biology at the single cell level.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/10/2016 via PR Newswire

Sunquest Information Systems, acquired UNIConnect LC

synopsis: Provider of diagnostics informatics solutions to more than 1,700 laboratories, Sunquest Information Systems, Inc. announced the acquisition of the Salt Lake City-based software firm UNIConnect® L.C. UNIConnect specializes in software for molecular laboratories and augments Sunquest's molecular diagnostics solution.
buyer parent: Roper Technologies, Inc.
buyer: Sunquest Information Systems
Sunquest Information Systems Inc. provides diagnostics informatics solutions to more than 1,700 laboratories. Since 1979, Sunquest has helped laboratories and healthcare organizations across the world optimize financial results, enhance efficiency and improve the quality of patient care. "
target: UNIConnect LC
Based in Salt Lake City, UT, UNIConnect® L.C. has created a Laboratory Information Management System (LIMS) platform that marries breakthrough software technology with unparalleled customization and configuration control to advance the "omic" sciences and precision medicine.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/1/2015 via BusinessWire

Ambry Genetics, acquired Progeny Software Inc.

synopsis: Ambry Genetics announced the acquisition of Progeny Software, LLC. This acquisition marries the premier clinical genetics laboratory with the gold standard pedigree software company, effectively redefining Ambry as a complete genetics services company on the forefront of personalized medicine.
buyer: Ambry Genetics
Ambry leads in clinical genetic diagnostics and genetics software solutions, combining both to offer the most comprehensive testing menu in the industry. Ambry has established a reputation for sharing data while safeguarding patient privacy and unparalleled service. "
target: Progeny Software Inc.
Progeny has increasingly enhanced the technology required to manage all types of genetic data. Whether it be related to pedigrees, providing genotype management and analysis, or providing a full LIMS system, Progeny is committed to bring solutions to the table for the customers they serve.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/10/2018 via BusinessWire

Zymergen, acquired Radiant Genomics

synopsis: Zymergen, a molecular technology company, announced the acquisition of Radiant Genomics, a leader in functional metagenomics research. Radiant Genomics has developed a robust industrial platform for natural product and gene discovery that allows scientists to rapidly identify, produce, and test products encoded in the genomes of organisms.
buyer: Zymergen
Zymergen is a molecular technology company ushering in a new age of manufacturing and industrial innovation. Leveraging the power of machine learning, automation, and bioengineering, they discover new molecular products that touch every industry. "
target: Radiant Genomics
Radiant Genomics is a leader in functional metagenomics research. Radiant Genomics has developed a robust industrial platform for natural product and gene discovery that allows scientists to rapidly identify, produce, and test products encoded in the genomes of millions of organisms.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/7/2016 via PR Newswire

Elsevier B.V., acquired Hivebench

synopsis: Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced the acquisition of Hivebench, the flagship product of researcher application developer Shazino, based in Lyon, France. Hivebench is a digital laboratory notebook that helps researchers.
buyer parent: RELX Group plc
buyer: Elsevier B.V.
Elsevier is a provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. "
target parent: Shazino
target: Hivebench
Hivebench is a digital laboratory notebook that helps researchers prepare, conduct and analyze experiments, methods, and protocols in one place, saving them valuable time.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/16/2018 via PR Newswire

Sophia Genetics, acquired Interactive Biosoftware

synopsis: SOPHiA GENETICS, global leader in Data-Driven Medicine, announced that it has completed the acquisition of French-based tech company Interactive Biosoftware (IBS), the creators of Alamut®, the most used decision support software for clinical genomic data interpretation. Alamut® is currently deployed in over 450 hospitals.
buyer: Sophia Genetics
Based in Switzerland, SOPHiA GENETICS is a health tech company which has developed SOPHiA AI, the most advanced technology for clinical genomics, helping healthcare professionals better diagnose and treat patients. "
target: Interactive Biosoftware
Interactive Biosoftware was founded in Rouen, France, by a group of medical and computer scientists focusing on practical software applications for health care and life sciences, particularly in the field of genomics.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/14/2018 via BusinessWire

Illumina, Inc., acquired Edico Genome Inc.

synopsis: Illumina, Inc.  announced that it acquired Edico Genome, the leading provider of data analysis acceleration solutions for next-generation sequencing. Edico Genome’s DRAGEN Bio-IT Platform uses field programmable gate array technology in conjunction with proprietary software algorithms to reduce both data footprint and time to results.
buyer: Illumina, Inc. (ILMN:$3,556.00)
Illumina is improving human health by unlocking the power of the genome. Their focus on innovation has established them as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. "
target: Edico Genome Inc.
Based in San Diego and founded in 2013, Edico Genome Inc. develops cutting edge solutions that power the genomic revolution. Their vision is to revolutionize genome sequencing analysis by providing unprecedented speed, scale and accuracy.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/23/2017 via BusinessWire

Omicia, acquired Spiral Genetics

synopsis: Omicia, Inc., a leading provider of clinical genomic data analysis and reporting software, announced that it has acquired Seattle-based Spiral Genetics. Spiral’s advanced tools add multiple variant detection capabilities for next generation sequencing (NGS) to Omicia’s industry-leading software platform.
buyer: Omicia
Clinicians and scientists utilize Omicia’s tools to quickly process and analyze genomic data and ultimately improve patient outcomes. Headquartered in Oakland, California, Omicia was founded by renowned scientists and industry veterans who are pioneers in bioinformatics, genomics and diagnostics. "
target: Spiral Genetics
Headquartered in Seattle, WA, Spiral Genetics is a bioinformatics company that develops high performance software for analyzing next-generation sequencing data. They specialize in large-scale DNA data analysis for medical, pharmaceutical and agricultural research.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/12/2016 via BusinessWire

PierianDx, acquired Tute Genomics

synopsis: PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, announced the acquisition of Tute Genomics, a genomics software company based in Provo, UT. The acquisition furthers PierianDx’s goal to be the most comprehensive, integrated platform to enable personalized medicine for clinical labs.
buyer: PierianDx
Founded in 2011, PierianDx is the leading provider of genomic software. They enable health systems, academic medical centers and commercial labs to deliver patient-specific diagnosis and treatments based on an individual’s DNA. "
target: Tute Genomics
Tute Genomics provides a cloud-based genome informatics solution to help diagnostic labs and health systems process next-generation sequencing data in a secure fashion. Tute is powering the world's genomic knowledge through enterprise informatics, genome interpretation, and clinical insights.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/25/2016 via Company Press Release

Vela Diagnostics Pte. Ltd., purchased Data Interpretation Division from Lifecode, Inc.

synopsis: Vela Diagnostics announced that it has acquired the data interpretation division of Lifecode Inc., a Foster City, California-based cancer molecular company. The data interpretation products and services from Lifecode will be connected to Vela Diagnostics’ Next-Generation Sequencing Sentosa® SQ Reporter Software.
buyer: Vela Diagnostics Pte. Ltd.
Vela Diagnostics is a worldwide supplier of integrated life sciences and diagnostic solutions that help provide customers with valuable molecular information. It delivers innovative technology and products* that address many of the clinical, technical and economic issues facing laboratories. "
seller: Lifecode, Inc.
Lifecode Inc’s data interpretation service provides access to Lifecode’s data integration framework, interpretation and report generation pipelines. Lifecode is a specialized CLIA certified clinical laboratory focused on the genetic basis of human disease.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 5/4/2015 via BusinessWire

Agilent Technologies Inc., will acquire Cartagenia

synopsis: Agilent Technologies Inc. will acquire Cartagenia, a leading provider of software and services for clinical genetics and molecular pathology labs. Cartagenia provides software solutions for variant assessment and reporting of clinical genomics data from next-generation sequencing and microarrays.
buyer: Agilent Technologies Inc. (A:$4,720.00)
Agilent Technologies Inc. is a global leader in life sciences, diagnostics and applied chemical markets. Agilent works with customers in more than 100 countries, providing instruments, software, services and consumables for the entire laboratory workflow. "
target: Cartagenia
Cartagenia helps labs to confidently interpret, report and share genomic variants. Reduce turnaround time, build informed variant assessment pipelines, generate clinical grade lab reports, and manage increasing volumes of data. Bring together CNVs and molecular variation. Use clinical phenotypes.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/18/2020 via BusinessWire

Illumina, Inc., acquired BlueBee

synopsis: Illumina, Inc. is acquiring BlueBee, a cloud-based software company that provides genomics analysis solutions for research and clinical customers. BlueBee has developed a regulatory compliant, secure cloud platform that simplifies access to data and tools, enabling users to easily extract insights from genomic data.
buyer: Illumina, Inc. (ILMN:$3,556.00)
Illumina, Inc. is a biotechnology company. They provide sequencing and array-based solutions for genetic analysis. Their studies help accelerate the studies of personalized medicine and their products are used for applications in life sciences and other emerging health segments. "
target: BlueBee
BlueBee is a cloud-based software company that provides genomics analysis solutions for research and clinical customers. BlueBee has developed a regulatory compliant, secure cloud platform that simplifies access to data and tools, enabling users to easily extract insights from genomic data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/11/2020 via PR Newswire

InVitae, acquired Diploid

synopsis: Invitae Corporation, a leading medical genetics company, has acquired Diploid, a privately held Belgian company that developed Moon, artificial intelligence (A.I.) software capable of diagnosing genetic disorders in minutes based on next-generation sequencing data and patient information.
buyer: InVitae (NVTA:$216.82)
Invitae Corporation is a leading medical genetics company that brings comprehensive genetic information into mainstream medicine to improve healthcare. Invitae's goal is to aggregate the world's genetic tests into a single service with higher quality, faster turnaround time, and lower prices. "
target: Diploid
Belgium-based Diploid provides clinical labs, hospitals, and nation-wide sequencing programs with the tools to diagnose every rare disease patient. Its Moon platform uses AI software capable of diagnosing genetic disorders in minutes based on next-generation sequencing data and patient information.
price ($mm)
$95
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/30/2015 via PR Newswire

Human Longevity, Inc., acquired Cypher Genomics

synopsis: Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced that the company has acquired Cypher Genomics, Inc., a leading genome informatics company offering highly accurate, rapid and robust human genomic interpretation software solutions.
buyer: Human Longevity, Inc.
Human Longevity, Inc. (HLI) is the genomics-based, technology-driven company creating the world's largest database of whole genome, phenotype and clinical data. HLI is developing and applying large scale computing and learning to make novel discoveries to revolutionize the practice of medicine. "
target: Cypher Genomics
Cypher Genomics is a leading genome informatics company offering a highly accurate, rapid and robust interpretation software solution for users of human genome sequencing.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/6/2010 via Market Wire

CompareNetworks, Inc., purchased Two Titles from International Scientific Communications, Inc.

synopsis: CompareNetworks, Inc., a leading provider of online b-to-b marketplaces for the scientific and healthcare industries, acquired the titles of American Laboratory and American Biotechnology Laboratory from International Scientific Communications (ISC), Shelton, CT.
buyer parent: Alta Communications
buyer: CompareNetworks, Inc.
CompareNetworks operates targeted, online, b-to-b marketplaces for professionals worldwide. CompareNetworks integrates online marketplaces, email newsletters, video, whitepapers and editorial content to bring buyers and sellers together. "
seller: International Scientific Communications, Inc.
International Scientific Communications, Inc. publishes journals, editorial tabloids, and technical articles on analytical chemistry and life sciences for the chemists and life scientists. Its publications provide news and information in the biotechnology, drug discovery, and many others.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

By Thermo Fisher Scientific, Inc.


read more

HighChem, Ltd.

Core Informatics LLC

read more

HighChem, Ltd.

BSSN Software GmbH

OmicSoft Corporation

Bio-Rad Laboratories

Knome, Inc.

Cytobank

UNIConnect LC

Progeny Software Inc.

Radiant Genomics

Hivebench

Interactive Biosoftware

Edico Genome Inc.

Spiral Genetics

Tute Genomics

Lifecode, Inc.

Cartagenia

BlueBee

Diploid

Cypher Genomics

International Scientific Communications, Inc.

read more

HighChem, Ltd.

BSSN Software GmbH

OmicSoft Corporation

Bio-Rad Laboratories

Knome, Inc.

Cytobank

UNIConnect LC

Progeny Software Inc.

Radiant Genomics

Hivebench

Interactive Biosoftware

Edico Genome Inc.

Spiral Genetics

Tute Genomics

Lifecode, Inc.

Cartagenia

BlueBee

Diploid

Cypher Genomics

International Scientific Communications, Inc.

Geography
Matching Companies
Ticker: TMO
 
 
 
 
 
 
 
 
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific Inc. offers an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. They help customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity.
year
2019
rev ($mm)
$24,630.00
EBITDA ($mm)
$6,242.00
EBIT ($mm)
$3,995.00
Net Income ($mm)
$3,174.00
Employees
70000
  • drill down
  • watch
Ticker: ILMN
 
 
 
 
 
 
 
 
Illumina, Inc.
Illumina, Inc.
Illumina is improving human health by unlocking the power of the genome. Their focus on innovation has established them as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets.
year
2020
rev ($mm)
$3,556.00
EBITDA ($mm)
$1,198.00
EBIT ($mm)
$1,013.00
Net Income ($mm)
$942.00
Employees
7700
  • drill down
  • watch
Ticker: BIO
 
 
 
 
 
 
 
 
Bio-Rad Laboratories
Bio-Rad Laboratories
Bio-Rad Laboratories, Inc. is a manufacturer of products for the life science research and clinical diagnostics markets. The company was founded in 1952 in Berkeley, California
year
2019
rev ($mm)
$2,311.66
EBITDA ($mm)
$387.06
EBIT ($mm)
$252.86
Net Income ($mm)
$1,758.68
Employees
8120
  • drill down
  • watch
Ticker: TMO
 
 
 
 
 
 
 
 
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific Inc. offers an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. They help customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity.
year
2019
rev ($mm)
$24,630.00
EBITDA ($mm)
$6,242.00
EBIT ($mm)
$3,995.00
Net Income ($mm)
$3,174.00
Employees
70000
  • drill down
  • watch
Ticker: ILMN
 
 
 
 
 
 
 
 
Illumina, Inc.
Illumina, Inc.
Illumina is improving human health by unlocking the power of the genome. Their focus on innovation has established them as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets.
year
2020
rev ($mm)
$3,556.00
EBITDA ($mm)
$1,198.00
EBIT ($mm)
$1,013.00
Net Income ($mm)
$942.00
Employees
7700
  • drill down
  • watch
Ticker: BIO
 
 
 
 
 
 
 
 
Bio-Rad Laboratories
Bio-Rad Laboratories
Bio-Rad Laboratories, Inc. is a manufacturer of products for the life science research and clinical diagnostics markets. The company was founded in 1952 in Berkeley, California
year
2019
rev ($mm)
$2,311.66
EBITDA ($mm)
$387.06
EBIT ($mm)
$252.86
Net Income ($mm)
$1,758.68
Employees
8120
  • drill down
  • watch